Investment, pandemic pivot spur success for genomics company
Genemarkers has seen a surge in business due to COVID-19 testing. KALAMAZOO, Mich.—The expansion of COVID-19 testing, while playing a large part in pandemic mitigation strategies across Michigan, also fueled genomics research company Genemarkers' exponential growth. It's an accomplishment being celebrated by the Biosciences Research and Commercialization Center (BRCC) of Western Michigan University—a nonprofit that invests in early stage life science startups across the state. Genemarkers, which applies state-of-the-art genomics technologies to research and development, initially formed a...
Source: wmich.edu